JyotishVed vs Lyfegen HealthTech AG: Which Is Better in 2026?

JyotishVed is a Vedic astrology platform that turns birth details into a precise sidereal birth chart and explains the result in clear, everyday English. It is designed for people who want to understand their Kundli without first learning complex astrological terminology.

The platform calculates charts using Swiss Ephemeris data and the Lahiri ayanamsa, which is widely used in Indian astrology. Users can view planetary positions, Lagna, Moon sign, houses and other chart details in North Indian or South Indian chart styles. JyotishVed then uses AI-assisted explanations based on traditional Vedic astrology rules to make the information easier to explore.

After creating a chart, users can examine their current and upcoming Dasha life periods, discover yogas or planetary combinations, review important transits and understand traditional interpretations of Sade Sati. The platform also includes Kundali Milan with Ashtakoota compatibility matching for marriage, as well as information about Muhurta, remedies and downloadable life reports.

Ask JyotishVed provides a conversational way to ask questions about your own chart. Instead of receiving only technical tables, users can ask about specific placements, periods or themes and receive a plain-language explanation connected to the birth chart they generated.

JyotishVed is free to start. The Free plan includes one birth chart, five AI chats and one Kundali Milan. Pro and Premium plans provide additional charts, conversations and deeper reports for users who want to explore further.

The website also offers free educational resources for people learning Vedic astrology. Its learning section includes explanations of 52 yogas, a plain-language Jyotish glossary and articles about topics such as ayanamsa, Nakshatras and the difference between Vedic and Western astrology. A free Sade Sati calculator helps visitors check their approximate Saturn period and current phase without signing up.

Astrology is a traditional belief system rather than a scientifically proven method of prediction. JyotishVed presents its results as educational and interpretive guidance, not guaranteed outcomes or a substitute for professional medical, financial or legal advice.

Whether someone is generating a first Kundli or already understands Vedic astrology, JyotishVed brings calculations, learning resources and chart-based explanations together in one accessible platform.

What problem it solves

Traditional Kundli reports can be difficult for beginners to read. JyotishVed combines precise sidereal chart calculations with plain-language, chart-specific explanations, educational resources and an AI chat so users can understand their placements, dashas, yogas, transits and compatibility in one place.

Alternatives & competitors

AstroSage, ClickAstro, Astrotalk and Vedic Rishi

Lyfegen is an independent provider of cloud-based rebate management, drug pricing, and market access software designed for the healthcare industry. Founded in 2018 and headquartered in Basel, Switzerland, Lyfegen supports organizations across Europe, North America, and the Middle East.

Its solutions are used by health insurers, governments, hospital payers, and pharmaceutical companies to simplify complex drug pricing agreements, reduce administrative work, improve rebate compliance, and generate greater value from healthcare contracts. Payers and pharmaceutical companies are among Lyfegen’s key target customers.

Lyfegen’s platform combines rebate management and analytics, a drug contracting simulator, and a comprehensive agreements library. Its rebate management capabilities help healthcare organizations validate, analyze, and manage rebates more efficiently while reducing reliance on manual processes and improving financial oversight.

The drug contracting simulator allows users to model and compare different pricing, reimbursement, and contracting scenarios before agreements are implemented. Teams can test assumptions, assess potential financial outcomes, and evaluate different contract structures to support more informed pricing and negotiation decisions.

Lyfegen also maintains a large digital repository of innovative drug pricing models and publicly available agreements. This knowledge base helps users review existing approaches, conduct due diligence, benchmark potential agreements, and identify relevant contracting models across different healthcare markets.

The platform also supports value-based contracting and other innovative access models by helping organizations manage the design, implementation, monitoring, and analysis of complex agreements. By bringing these processes into one cloud-based environment, Lyfegen helps reduce administrative burden, improve transparency, and strengthen collaboration between healthcare stakeholders.

For pharmaceutical companies, Lyfegen supports pricing, market access, contracting, and rebate management activities. For payers, governments, insurers, and hospital organizations, the platform supports contract evaluation, rebate validation, financial analysis, and agreement management.

By combining simulation, analytics, rebate management, and market intelligence, Lyfegen helps healthcare organizations make more informed pricing and reimbursement decisions while making pharmaceutical contracting more efficient, transparent, and manageable.

What problem it solves

Lyfegen solves the complexity and administrative burden of managing drug pricing agreements, rebates, and value-based contracts in healthcare. Many payers and pharmaceutical companies still rely on fragmented systems, spreadsheets, and manual processes to design, monitor, validate, and analyze these agreements.

Lyfegen centralizes these activities in one cloud-based platform, helping organizations manage rebates more efficiently, simulate different pricing and contracting scenarios, improve compliance, and gain clearer visibility into the financial impact of their agreements. It also helps healthcare stakeholders reduce manual work, improve collaboration, and make more informed pricing, reimbursement, and market access decisions.